Back to search results

A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)

Abroad (travel likely)RecruitingPHASE2

Conditions

Narcolepsy Type 2

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Takeda Site 36, Auburn, Alabama, United States

  • Takeda Site 39, Chandler, Arizona, United States

  • Takeda Site 40, Chula Vista, California, United States

  • Takeda Site 14, Redwood City, California, United States

  • Takeda Site 10, Santa Ana, California, United States

  • Takeda Site 1, Colorado Springs, Colorado, United States

  • Takeda Site 48, Bradenton, Florida, United States

  • Takeda Site 13, Brandon, Florida, United States

  • Takeda Site 46, Jacksonville, Florida, United States

  • Takeda Site 44, Miami, Florida, United States

  • Takeda Site 35, Miami, Florida, United States

  • Takeda Site 3, Orlando, Florida, United States

  • Takeda Site 33, Orlando, Florida, United States

  • Takeda Site 32, Atlanta, Georgia, United States

  • Takeda Site 49, Bowie, Maryland, United States

  • Takeda Site 50, Lansing, Michigan, United States

  • Takeda Site 34, Lathrup Village, Michigan, United States

  • Takeda Site 4, St Louis, Missouri, United States

  • Takeda Site 37, Middletown, New Jersey, United States

  • Takeda Site 8, Denver, North Carolina, United States

  • Takeda Site 6, Huntersville, North Carolina, United States

  • Takeda Site 41, Winston-Salem, North Carolina, United States

  • Takeda Site 5, Cincinnati, Ohio, United States

  • Takeda Site 45, Cleveland, Ohio, United States

  • Takeda Site 2, Columbia, South Carolina, United States

  • Takeda Site 38, Austin, Texas, United States

  • Takeda Site 43, Dallas, Texas, United States

  • Takeda Site 42, El Paso, Texas, United States

  • Takeda Site 47, Mansfield, Texas, United States

  • Takeda Site 7, San Antonio, Texas, United States

  • Takeda Site 11, Norfolk, Virginia, United States

  • Takeda Site 28, Beijing, Beijing Municipality, China

  • Takeda Site 29, Guangzhou, Guangzhou, China

  • Takeda Site 51, Changchun, Jilin, China

  • Takeda Site 27, Shanghai, Shanghai Municipality, China

  • Takeda Site 17, Montpellier, Hérault, France

  • Takeda Site 15, Paris, France

  • Takeda Site 22, Rome, Lazio, Italy

  • Takeda Site 31, Verona, Veneto, Italy

  • Takeda Site 23, Bologna, Italy

  • Takeda Site 24, Kohoku-ku, Yokohama-Shi, Kanagawa, Japan

  • Takeda Site 9, Kumamoto, Kumamoto, Japan

  • Takeda Site 53, Isahaya-shi, Nagasaki, Japan

  • Takeda Site 30, Urasoe-Shi, Okinawa, Japan

  • Takeda Site 20, Shinjuku-ku, Tokyo, Japan

  • Takeda Site 26, Sumida-Ku, Tokyo, Japan

  • Takeda Site 52, Fukuoka, Japan

  • Takeda Site 12, Yodogawa-ku, Osaka-shi, Ôsaka, Japan

  • Takeda Site 16, Junggu, Daegu Gwang'yeogsi, South Korea

  • Takeda Site 19, Suwon, Gyeonggido, South Korea

  • Takeda Site 21, Seoul, Seoul Teugbyeolsi, South Korea

  • Takeda Site 18, Madrid, Spain

Study leads

  • Study Director

    Takeda

View source on ClinicalTrials.gov(opens in a new tab)